SOLICITATION NOTICE
68 -- CliniMACS Reagents
- Notice Date
- 6/23/2006
- Notice Type
- Solicitation Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- NCI-60093-NG
- Response Due
- 7/5/2006
- Archive Date
- 7/20/2006
- Description
- The National Cancer Institute (NCI), Center for Cancer Research (CCR), Surgery Branch (SB) plans to procure on a sole source basis for: CliniMACS CD25 reagents, CD3 Reagents CD8 reagents, tubing sets, and PBS/EDTA buffer from Miltenyi Biotech, Inc., 12740 Earhart Avenue, Auburn, California 95602. This acquisition will be processed under FAR Part 12, Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13 to use simplified procedures for commercial acquisitions. The North American Industry Classification System Code is 325414 and the business size standard is 500 employees. Enrichment of depletion of cell populations from peripheral blood mononuclear cell preparations is an integral part of ongoing Surgery Branch clinical protocols. Depletion of CD25 cells, depletion of CD3 cells, and enrichment of CD8 cells are required for five active clinical protocols for patients with metastatic renal cell cancer or melanoma. Ongoing protocols in the Surgery Branch are investigating the use of subsets of peripheral blood mononuclear cells to improve and extend this therapy approach. These critical clinical-grade reagents are required for our clinical protocols and are manufactured and distributed solely by Miltenyi Biotec Inc. Miltenyi Biotec Inc. is the only known source to the NCI that can meet the aforementioned requirement. Changing variables at this time will be detrimental to the current clinical trials in progress. This is not a solicitation for competitive quotations. However, if any interested party believes it can meet the above requirement, they may submit a statement of capabilities. All information furnished shall be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the contracting office by 1:00 PM EST on July 5, 2006. All questions must be in writing and can be faxed (301) 402-4513 or emailed to Malinda Holdcraft, Contract Specialist at holdcram@exchange.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. Contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) in order to receive an award. Please reference NCI-60093-NG on all correspondence.
- Record
- SN01076426-W 20060625/060623220348 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |